# The PREDICT Registry:

> **NCT03448926** · — · RECRUITING · sponsor: **PreludeDx** · enrollment: 3000 (estimated)

## Conditions studied

- DCIS
- Stage 0 Breast Cancer
- Ductal Breast Carcinoma In Situ

## Interventions

- **OTHER:** Treatment recommendation surveys
- **DEVICE:** 7-gene biosignature

## Key facts

- **NCT ID:** NCT03448926
- **Lead sponsor:** PreludeDx
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2018-02-27
- **Primary completion:** 2026-12
- **Final completion:** 2036-12
- **Target enrollment:** 3000 (ESTIMATED)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03448926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03448926, "The PREDICT Registry:". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03448926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*